--- title: "Mountain Crest Acquisition Corp. V (MCAG) stock" url: "https://aibio.space/companies/mountain-crest-acquisition-v/" publisher: "aibio.space (Biotech Investor Relations News)" summary: "Mountain Crest Acquisition Corp. V (OTC: MCAG), United States. Listing facts, related biotech companies and news on aibio.space." --- MCAG Mountain Crest Acquisition Corp. V OTC · United States # Mountain Crest Acquisition Corp. V (MCAG) news Mountain Crest Acquisition Corp. V is a public biotech or pharmaceutical company listed on OTC under the ticker MCAG, recorded under United States. aibio.space tracks 2,820 public biotech companies worldwide and publishes investor news on them. ## Latest Mountain Crest Acquisition Corp. V news We have not published a story on Mountain Crest Acquisition Corp. V yet. When there is news, it will appear here. ## Mountain Crest Acquisition Corp. V at a glance - **Ticker**: MCAG - **Listing**: OTC - **Country**: United States - **Cash, Jun 30, 2026**: $18,299 ### Related companies - [PROCYON CORP](https://aibio.space/companies/procyon/) OTC: PCYN - [Electromed](https://aibio.space/companies/electromed/) NYSE: ELMD - [Envista Holdings](https://aibio.space/companies/envista/) NYSE: NVST - [SI-BONE](https://aibio.space/companies/si-bone/) NASDAQ: SIBN - [YD Bio](https://aibio.space/companies/yd-bio/) NASDAQ: YDES - [Medinotec](https://aibio.space/companies/medinotec/) OTC: MDNC - [Embecta](https://aibio.space/companies/embecta/) NASDAQ: EMBC - [IRIDEX CORP](https://aibio.space/companies/iridex/) NASDAQ: IRIX ### Also on OTC - [Statera Biopharma](https://aibio.space/companies/statera-biopharma/) STAB - [CERo Therapeutics Holdings](https://aibio.space/companies/cero-therapeutics/) CERO - [Vaxxinity](https://aibio.space/companies/vaxxinity/) VAXX - [Bespoke Extracts](https://aibio.space/companies/bespoke-extracts/) BSPK - [CV Sciences](https://aibio.space/companies/cv-sciences/) CVSI - [CYANOTECH CORP](https://aibio.space/companies/cyanotech/) CYAN ## Mountain Crest Acquisition Corp. V annual financials | Line | FY2025 | FY2024 | |---|---|---| | Net income (loss) | [-$431,161](https://www.sec.gov/Archives/edgar/data/1859035/000182912626002303/) | [-$374,454](https://www.sec.gov/Archives/edgar/data/1859035/000182912626002303/) | | Cash from operations | [-$741,998](https://www.sec.gov/Archives/edgar/data/1859035/000182912626002303/) | [-$921,200](https://www.sec.gov/Archives/edgar/data/1859035/000182912626002303/) | | Cash and equivalents | [$11,909](https://www.sec.gov/Archives/edgar/data/1859035/000182912626008901/) | [$116,658](https://www.sec.gov/Archives/edgar/data/1859035/000182912626008901/) | Latest balance sheet, Jun 30, 2026 (10-Q): cash and equivalents $18,299. Figures as reported to the SEC in XBRL; each one links to its filing. Not adjusted, not investment advice. ## Questions about Mountain Crest Acquisition Corp. V What is the ticker symbol of Mountain Crest Acquisition Corp. V? Mountain Crest Acquisition Corp. V trades under the ticker MCAG on OTC. Where is Mountain Crest Acquisition Corp. V listed? Mountain Crest Acquisition Corp. V is listed on OTC. Which country or territory is Mountain Crest Acquisition Corp. V listed under? Our directory records Mountain Crest Acquisition Corp. V under United States. Does aibio.space cover Mountain Crest Acquisition Corp. V? aibio.space lists Mountain Crest Acquisition Corp. V among 2,820 public biotech companies and publishes its news here as stories appear. Is Mountain Crest Acquisition Corp. V profitable? Mountain Crest Acquisition Corp. V reported a net loss of $431,161 for the fiscal year ended Dec 31, 2025, and used $741,998 of cash in operations, per its annual report to the SEC. How much cash does Mountain Crest Acquisition Corp. V have? $18,299 in cash at Jun 30, 2026, per its 10-Q. ## Investor discussion: Mountain Crest Acquisition Corp. V Members talk about Mountain Crest Acquisition Corp. V (MCAG). Reader posts, not aibio.space reporting, and not investment advice. Rules 1. **Securities violations are strictly forbidden.** No market manipulation, no pump-and-dump, no false or misleading statements, and no inside information. 2. **Say whether you hold the stock.** Every post states long, short or no position. 3. **No paid or sponsored posts.** Do not post for anyone who pays or rewards you. 4. **No buy or sell calls and no price targets.** 5. **No accusations of crime or fraud against named people** unless you link a court filing or a regulator's release that makes them. 6. **No personal details and no spam.** No links at all for your first 7 days as a member. Posts that break the rules may be deleted without notice, and the account restricted or closed. See the [terms](https://aibio.space/terms/#discussion) and the [privacy policy](https://aibio.space/privacy/#discussion). ## Capital-markets timeline Financings, listing notices, splits, legal actions and other investor events at Mountain Crest Acquisition Corp. V, newest first. Each line links the filing it comes from. 1. 2026-10-20 Mergers Filed documents for a merger or acquisition. SEC Form DEFM14A. [Source](https://www.sec.gov/Archives/edgar/data/1859035/000182912626011337/mountaincrest5_defm14a.htm) ## Stock chart Price chart and quote supplied by TradingView, delayed as the exchange requires. It loads only if you choose to show it. Information only, not investment advice. [Open OTC:MCAG on TradingView](https://www.tradingview.com/symbols/OTC-MCAG/). ## Listing details Mountain Crest Acquisition Corp. V is a public biotech or pharmaceutical company listed on OTC under the ticker MCAG, recorded under United States. aibio.space tracks 2,820 public biotech companies worldwide and publishes investor news on them. - **Company**: Mountain Crest Acquisition Corp. V - **Ticker**: MCAG - **Listing**: OTC - **Country or territory**: United States Listing facts come from our company directory, researched on October 22, 2026. A listing record does not certify that a security currently trades. [Tell us about a change](https://aibio.space/reputation/#update). Work at this company? [Claim this page](https://aibio.space/claim/). Published and maintained by aibio.space. Not investment advice. [How we work](https://aibio.space/disclosures/). Who manages this page **This page is managed by aibio.space.** The company does not run, edit or pay for this page. News, desk views and Investor Ranks are written and managed independently by aibio.space under our editorial and analytical judgment. Opinion only, not investment advice. [How we work](https://aibio.space/disclosures/#paid) · [Terms](https://aibio.space/terms/#news) · [Request a correction](https://aibio.space/reputation/#update) --- Source page: https://aibio.space/companies/mountain-crest-acquisition-v/. Facts in aibio.space stories are checked against company filings and releases; opinion is labelled. Cite as: aibio.space, "Mountain Crest Acquisition Corp. V (MCAG) stock", 2026-10-31, https://aibio.space/companies/mountain-crest-acquisition-v/